Vivien Wong
Directeur/Bestuurslid bij CYCLO THERAPEUTICS, INC.
Vermogen: 11 375 $ op 30-04-2024
Profiel
Vivien Wong is currently an Independent Director at Cyclo Therapeutics, Inc. since 2023 and a Director at Burke Neurological Institute since 2022.
Previously, Dr. Wong worked as the Vice President-Product Development at Progenics Pharmaceuticals, Inc. from 2007 to 2021 and as a Principal at Theritas Pharmaceutical Consultants from 2004 to 2007.
Dr. Wong completed an undergraduate degree at Mississippi University for Women and a doctorate degree at the University of Maryland School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CYCLO THERAPEUTICS INC
0.03% | 01-03-2024 | 8 818 ( 0.03% ) | 11 375 $ | 30-04-2024 |
Actieve functies van Vivien Wong
| Bedrijven | Functie | Begin |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | Directeur/Bestuurslid | 17-08-2023 |
| Burke Neurological Institute | Directeur/Bestuurslid | 01-01-2022 |
Eerdere bekende functies van Vivien Wong
| Bedrijven | Functie | Einde |
|---|---|---|
| Theritas Pharmaceutical Consultants | Corporate Officer/Principal | 01-09-2007 |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Vivien Wong
| Mississippi University for Women | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Theritas Pharmaceutical Consultants | |
| Burke Neurological Institute |